Ticker
OCULCompany Name
OCULAR THERAPEUTIX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 451.33M | $ 392.75M | 87.02% |
3/31/2025 | $ 405.92M | $ 351.3M | 86.54% |
12/31/2024 | $ 457.94M | $ 393.72M | 85.98% |
9/30/2024 | $ 490.37M | $ 428.83M | 87.45% |
6/30/2024 | $ 517.09M | $ 461.3M | 89.21% |
3/31/2024 | $ 538.95M | $ 484.65M | 89.93% |
12/31/2023 | $ 252.06M | $ 197.57M | 78.38% |
9/30/2023 | $ 162.38M | $ 112.31M | 69.17% |
6/30/2023 | $ 122.56M | $ 68.37M | 55.79% |
3/31/2023 | $ 128.57M | $ 80.79M | 62.84% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for OCULAR THERAPEUTIX INC is calculated as follows: CashnEq [ $ 72.41M ] / Assets [ $ 98.22M ]
(=) Cash to Assets [ 73.72% ]
Minimum
Jun 30, 2023
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.89% |
average | 9.83% |
median | 6.44% |
std | 9.6% |